Alarcón, R. D. (2009). Culture, cultural factors and psychiatric diagnosis: Review and projections. World Psychiatry, 8(3), 131.
Article PubMed PubMed Central Google Scholar
American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th TR ed.). https://doi.org/10.1176/appi.books.9780890425787
BBC. (2023). Private ADHD clinics exposed. Panorama. https://www.bbc.co.uk/programmes/m001m0f9. Accessed 31 May 2024
Bell, L., Long, S., Garvan, C., & Bussing, R. (2011). The impact of teacher credentials on ADHD stigma perceptions. Psychology in the Schools, 48(2), 184–197. https://doi.org/10.1002/pits.20536
Catalá-López, F., Hutton, B., Núñez-Beltrán, A., Page, M. J., Ridao, M., Macías Saint-Gerons, D., Catalá, M. A., Tabarés-Seisdedos, R., & Moher, D. (2017). The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials. PLoS ONE, 12(7), e0180355.
Article PubMed PubMed Central Google Scholar
Chan, A. Y. L., Ma, T.-T., Lau, W. C. Y., Ip, P., Coghill, D., Gao, L., Jani, Y. H., Hsia, Y., Wei, L., Taxis, K., Simonoff, E., Taylor, D., Lum, T. Y., Man, K. K. C., & Wong, I. C. K. (2023). Attention-deficit/hyperactivity disorder medication consumption in 64 countries and regions from 2015 to 2019: A longitudinal study. EClinicalMedicine, 58, 101780. https://doi.org/10.1016/j.eclinm.2022.101780
Chen, H., Yang, Y., Odisho, D., Wu, S., Yi, C., & Oliver, B. G. (2023). Can biomarkers be used to diagnose attention deficit hyperactivity disorder? [Review]. Frontiers in Psychiatry, 14. https://doi.org/10.3389/fpsyt.2023.1026616
Coghill, D., Banaschewski, T., Cortese, S., Asherson, P., Brandeis, D., Buitelaar, J., Daley, D., Danckaerts, M., Dittmann, R. W., Doepfner, M., Ferrin, M., Hollis, C., Holtmann, M., Paramala, S., Sonuga-Barke, E., Soutullo, C., Steinhausen, H.-C., Van der Oord, S., Wong, I. C. K., . . . Simonoff, E. (2021). The management of ADHD in children and adolescents: bringing evidence to the clinic: perspective from the European ADHD Guidelines Group (EAGG). European Child & Adolescent Psychiatry. https://doi.org/10.1007/s00787-021-01871-x
Danckaerts, M., Sonuga-Barke, E. J. S., Banaschewski, T., Buitelaar, J., Döpfner, M., Hollis, C., Santosh, P., Rothenberger, A., Sergeant, J., Steinhausen, H.-C., Taylor, E., Zuddas, A., & Coghill, D. (2010). The quality of life of children with attention deficit/hyperactivity disorder: A systematic review. European Child & Adolescent Psychiatry, 19(2), 83–105. https://doi.org/10.1007/s00787-009-0046-3
Daojuin, D. L., Ching, O. S., Yi, G. J., Ying, L. Z., & Menon, T. (2021). Gender Equality and the Healthcare Workforce. Retrieved 08.04.2024 from https://static1.squarespace.com/static/5e477eb18ae6b644167d06ab/t/604d824c8e57d50afdcbd10d/1615692375261/Policy-2021-03-Gender-Equality-and-the-Healthcare-Workforce.pdf
Doggett, A. M. (2004). ADHD and drug therapy: Is it still a valid treatment? J Child Health Care, 8(1), 69–81. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15090116.
Evans, S. W., Owens, J. S., & Bunford, N. (2014). Evidence-based psychosocial treatments for children and adolescents with attention-deficit/hyperactivity disorder. Journal of Clinical Child & Adolescent Psychology, 43(4), 527–551.
Faraone, S. V., Biederman, J., Spencer, T., Wilens, T., Seidman, L. J., Mick, E., & Doyle, A. E. (2000). Attention-deficit/hyperactivity disorder in adults: An overview. Biological Psychiatry, 48(1), 9–20. https://doi.org/10.1016/s0006-3223(00)00889-1
Field, A. (2013). Discovering statistics using IBM SPSS statistics. Sage.
Fredriksen, M., Halmøy, A., Faraone, S. V., & Haavik, J. (2013). Long-term efficacy and safety of treatment with stimulants and atomoxetine in adult ADHD: A review of controlled and naturalistic studies. European Neuropsychopharmacology, 23(6), 508–527. https://doi.org/10.1016/j.euroneuro.2012.07.016
Frigerio, A., Montali, L., & Fine, M. (2013). Attention deficit/hyperactivity disorder blame game: A study on the positioning of professionals, teachers and parents. Health, 17(6), 584–604. https://doi.org/10.1177/1363459312472083
Fuermaier, A. B., Tucha, L., Koerts, J., Mueller, A. K., Lange, K. W., & Tucha, O. (2012). Measurement of stigmatization towards adults with attention deficit hyperactivity disorder. PLoS ONE, 7(12), e51755. https://doi.org/10.1371/journal.pone.0051755
Article PubMed PubMed Central Google Scholar
Goode, A. P., Coeytaux, R. R., Maslow, G. R., Davis, N., Hill, S., Namdari, B., LaPointe, N. M. A., Befus, D., Lallinger, K. R., Bowen, S. E., Kosinski, A., McBroom, A. J., Sanders, G. D., & Kemper, A. R. (2018). Nonpharmacologic treatments for attention-deficit/hyperactivity disorder: A systematic review. Pediatrics, 141(6). https://doi.org/10.1542/peds.2018-0094
Grimmsmann, T., & Himmel, W. (2021). The 10-year trend in drug prescriptions for attention-deficit/hyperactivity disorder (ADHD) in Germany. European Journal of Clinical Pharmacology, 77(1), 107–115. https://doi.org/10.1007/s00228-020-02948-3
Hadi, N. N. A., & Shah, N. M. (2022). Malaysian parental attitudes toward medicine use in children. Medical Journal of Malaysia, 77(1), 27.
Hanafiah, A. N., & Van Bortel, T. (2015). A qualitative exploration of the perspectives of mental health professionals on stigma and discrimination of mental illness in Malaysia. International Journal of Mental Health Systems, 9(1), 1–12.
Jusoh, M., Dzulkarnain, A. A. A., Rahmat, S., Musa, R., & Che Azemin, M. Z. (2021). Cross-cultural translation and validation of the Malay version of the Swanson, Nolan, and Pelham Parent Rating Scale of attention deficit hyperactivity disorders symptoms among Malaysian probands: A preliminary study. Asia-Pacific Psychiatry, 13(2), e12414. https://doi.org/10.1111/appy.12414
Kato, T. A., Tateno, M., Umene-Nakano, W., Balhara, Y. P., Teo, A. R., Fujisawa, D., Sasaki, R., Ishida, T., & Kanba, S. (2010). Impact of biopsychosocial factors on psychiatric training in Japan and overseas: Are psychiatrists oriented to mind, brain, or sociocultural issues? Psychiatry and Clinical Neurosciences, 64(5), 520–530. https://doi.org/10.1111/j.1440-1819.2010.02133.x
Article PubMed PubMed Central Google Scholar
Kellison, I., Bussing, R., Bell, L., & Garvan, C. (2010). Assessment of stigma associated with attention-deficit hyperactivity disorder: Psychometric evaluation of the ADHD Stigma Questionnaire. Psychiatry Research, 178(2), 363–369.
Article PubMed PubMed Central Google Scholar
Kendler, K. S. (2001). A psychiatric dialogue on the mind-body problem. American Journal of Psychiatry, 158(7), 989–1000.
Knight, S. (2022, 20th August). My adult ADHD drugs felt like a lifeline. Then came the scary side-effects …. The Guardian. https://www.theguardian.com/lifeandstyle/2022/aug/20/adhd-drugs-side-effects-prescription-stimulants
Kovshoff, H., Vrijens, M., Thompson, M., Yardley, L., Hodgkins, P., Sonuga-Barke, E. J., & Danckaerts, M. (2013). What influences clinicians’ decisions about ADHD medication? Initial data from the Influences on Prescribing for ADHD Questionnaire (IPAQ). European Child & Adolescent Psychiatry, 22(9), 533–542. https://doi.org/10.1007/s00787-013-0393-y
Lewczuk, K., Marcowski, P., Wizła, M., Gola, M., Nagy, L., Koós, M., Kraus, S. W., Demetrovics, Z., Potenza, M. N., Ballester-Arnal, R., Batthyány, D., Bergeron, S., Billieux, J., Briken, P., Burkauskas, J., Cárdenas-López, G., Carvalho, J., Castro-Calvo, J., Chen, L., . . . Bőthe, B. (2024). Cross-cultural adult ADHD assessment in 42 countries using the Adult ADHD Self-Report Scale Screener. Journal of Attention Disorders, 28(4), 512–530. https://doi.org/10.1177/10870547231215518
Miresco, M. J., & Kirmayer, L. J. (2006). The persistence of mind-brain dualism in psychiatric reasoning about clinical scenarios. American Journal of Psychiatry, 163(5), 913–918.
Moffitt, T. E., Houts, R., Asherson, P., Belsky, D. W., Corcoran, D. L., Hammerle, M., Harrington, H., Hogan, S., Meier, M. H., & Polanczyk, G. V. (2015). Is adult ADHD a childhood-onset neurodevelopmental disorder? Evidence from a four-decade longitudinal cohort study. American Journal of Psychiatry, 172(10), 967–977.
Moore, D. A., Richardson, M., Gwernan-Jones, R., Thompson-Coon, J., Stein, K., Rogers, M., Garside, R., Logan, S., & Ford, T. J. (2019). Non-pharmacological interventions for ADHD in school settings: An overarching synthesis of systematic reviews. Journal of Attention Disorders, 23(3), 220–233.
Mueller, A. K., Fuermaier, A. B., Koerts, J., & Tucha, L. (2012). Stigma in attention deficit hyperactivity disorder. ADHD Attention Deficit and Hyperactivity Disorders, 4, 101–114.
Nazarova, V. A., Sokolov, A. V., Chubarev, V. N., Tarasov, V. V., & Schiöth, H. B. (2022). Treatment of ADHD: Drugs, psychological therapies, devices, complementary and alternative methods as well as the trends in clinical trials. Frontiers in Pharmacology, 13. https://doi.org/10.3389/fphar.2022.1066988
NHS England. (2023). Gender pay gap report 2022: A combined report for NHS England and NHS Improvement. Retrieved 08.04.2024 from https://www.england.nhs.uk/long-read/gender-pay-gap-report-2022/
NICE. (2019). Attention deficit hyperactivity disorder: Diagnosis and management. https://www.nice.org.uk/guidance/ng87. Accessed 31 May 2024
Olusanya, B. O., Davis, A. C., Wertlieb, D., Boo, N.-Y., Nair, M., Halpern, R., Kuper, H., Breinbauer, C., De Vries, P. J., & Gladstone, M. (2018). Developmental disabilities among children younger than 5 years in 195 countries and territories, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. The Lancet Global Health, 6(10), e1100–e1121.
Pomare, C., Churruca, K., Ellis, L. A., Long, J. C., & Braithwaite, J. (2019). A revised model of uncertainty in complex healthcare settings: A scoping review. Journal of Evaluation in Clinical Practice, 25(2), 176–182.
Quintero, J., Ramos-Quiroga, J. A., Sebastián, J. S., Montañés, F., Fernández-Jaén, A., Martínez-Raga, J., Giral, M. G., Graell, M., Mardomingo, M. J., Soutullo, C., Eiris, J., Téllez, M., Pamias, M., Correas, J., Sabaté, J., García-Orti, L., & Alda, J. A. (2018). Health care and societal costs of the management of children and adolescents with attention-deficit/hyperactivity disorder in Spain: A descriptive analysis. BMC Psychiatry, 18(1), 40. https://doi.org/10.1186/s12888-017-1581-y
Article PubMed PubMed Central Google Scholar
Rafalovich, A. (2005). Exploring clinician uncertainty in the diagnosis and treatment of attention deficit hyperactivity disorder. Sociology of Health & Illness, 27(3), 305–323. https://doi.org/10.1111/j.1467-9566.2005.00444.x
Raman, S. R., Man, K. K. C., Bahmanyar, S., Berard, A., Bilder, S., Boukhris, T., Bushnell, G., Crystal, S., Furu, K., KaoYang, Y.-H., Karlstad, Ø., Kieler, H., Kubota, K., Lai, E. C.-C., Martikainen, J. E., Maura, G., Moore, N., Montero, D., Nakamura, H., . . . Wong, I. C. K. (2018). Trends in attention-deficit hyperactivity disorder medication use: A retrospective observational study using population-based databases. The Lancet Psychiatry, 5(10), 824–835. https://doi.org/10.1016/S2215-0366(18)30293-1
Robledo-Castro, C., Hederich-Martínez, C., & Montoya-Londoño, D. M. (2024). Psychometric characteristics of the Knowledge of Attention Deficit Hyperactivity Disorder Scale (KADDS) in a sample of Colombian teachers. Children and Youth Services Review, 156, 107374. https://doi.org/10.1016/j.childyouth.2023.107374
留言 (0)